The role of aberrant gene expression in chlamydial persistence and reactivation
异常基因表达在衣原体持续存在和重新激活中的作用
基本信息
- 批准号:10449373
- 负责人:
- 金额:$ 18.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-13 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAntibiotic TherapyAntibioticsAtherosclerosisBacteriaBiological AssayBiologyBlindnessCategoriesCell divisionCellsChlamydiaChlamydia InfectionsChlamydia trachomatisChlamydialesChlamydophila pneumoniaeChlamydophila psittaciChronicClinicalCollectionDataDevelopmentDevelopmental GeneDiagnosisDiseaseEukaryotic CellExcisionEye InfectionsGene ExpressionGene Expression ProfileGrowthHourHumanInfectionIronKineticsLeadLife Cycle StagesLiftingLinkMicroscopicModelingMolecularMorbidity - disease rateNutrientParasitesPathogenesisPatternPeptidoglycanPersonsPharmaceutical PreparationsPhenotypePneumoniaPolyploidyProcessProductionReporterReporter GenesReportingReproductive HealthRespiratory DiseaseRoleSexually Transmitted DiseasesStarvationStressSystemTestingTimeTrachomaTreatment FailureTryptophanVertebratesWomen&aposs HealthZoonosescell typechronic infectiondesignenvironmental stressorfallshuman pathogeninhibitorlive cell imaginglive cell microscopymemberpathogenic bacteriapromoterrecurrent infectionresponsetranscriptome sequencing
项目摘要
Project Summary/Abstract:
The bacteria in the Chlamydiales order are intracellular parasites of eukaryotic cells. They are reliant on a de-
velopmental cycle consisting of three cell forms termed the reticulate body (RB), the intermediate body (IB) and
the elementary body (EB). The EB is infectious but does not replicate. The RB replicates in the host cell but is
non-infectious, while the IB is an intermediate form that transitions to the EB form. Completion of this develop-
mental cycle is central to chlamydial pathogenesis. Within this order, the genus Chlamydia contains the
causative agents of a number of important pathogens of humans. C. psittaci causes zoonotic infections result-
ing in pneumonia, while C. pneumoniae is a human pathogen that causes respiratory disease and is linked to
atherosclerosis. Biovars of C. trachomatis are the causative agents of trachoma, the leading cause of pre-
ventable blindness worldwide, as well as the sexually transmitted disease Chlamydia. Irrespective of the result-
ing disease, all chlamydial species share the same obligate intracellular life cycle and developmental cycle.
The chlamydial developmental cycle reacts to environmental stresses by exiting the developmental cycle and
forming “aberrant” cell forms and delaying the production of infectious EBs. These cell forms can then reenter
the productive developmental cycle when the environmental stress is lifted. It is hypothesized that this re-
sponse to stress conditions contributes to the clinical observation that chlamydial infections are often chronic or
reoccur in a significant number of diagnosed cases. We have developed a live-cell reporter system to follow
cell-type switching in real time at the single inclusion level and determined that Chlamydia’s response to stress
conditions such as peptidoglycan inhibitors or nutrient stress differs between treatments and over time. Treat-
ment with peptidoglycan inhibitors results in a block in RB to IB development creating aberrant polyploid RBs.
These aberrant cells express the RB reporter for ~ 10 hours prior to expressing the IB reporter but never ex-
press EB reporters or gain infectivity. Nutrient stress such as tryptophan and iron starvation are also reported
to cause Chlamydia to exit the productive developmental cycle and form “aberrant” RBs. Our live cell data
suggests that these cells do not exhibit the same phenotype as those treated with peptidoglycan inhibitors.
Therefore Aim 1 will Determine the phenotype and gene expression profile of aberrant RBs that reacti-
vate to produce infectious EBs. IB to EB development is a slow process taking ~10 hours until maximal EB
reporter gene expression. We therefore hypothesize that the IB may respond to nutrient stress by halting de-
velopment until the nutrient stress is resolved. The IB then could reenter the developmental state producing
infectious progeny. Therefore Aim 2 will Determine the contribution of the IB to EB transition in persis-
tence.
项目概要/摘要:
衣原体目中的细菌是真核细胞的细胞内寄生物。他们依赖于一种...
生殖周期由三种细胞形式组成,称为网状体(RB)、中间体(IB)和
基本体(EB)。EB病毒具有传染性,但不会复制。RB在宿主细胞中复制,
非传染性,而IB是过渡到EB形式的中间形式。完成这一发展-
心理周期是衣原体发病机制的核心。在该目中,衣原体属包含
许多重要的人类病原体的病原体。C.鹦鹉热导致人畜共患传染病,
在肺炎中,C.肺炎是一种引起呼吸道疾病的人类病原体,
动脉粥样硬化Biovars of C.沙眼是沙眼的病原体,
世界范围内的致盲症,以及性传播疾病衣原体。不管结果如何-
在疾病中,所有衣原体物种共享相同的专性细胞内生活周期和发育周期。
衣原体发育周期通过退出发育周期对环境压力作出反应,
形成“异常”细胞形式并延迟感染性EB的产生。这些细胞形式可以重新进入
环境压力解除后的生产发展周期。据推测,这一重新-
对应激条件的反应有助于临床观察,即衣原体感染通常是慢性的,
在大量确诊病例中复发。我们开发了一个活细胞报告系统
细胞类型转换在真实的时间在单一的包含水平,并确定衣原体的反应,以压力
条件如肽聚糖抑制剂或营养胁迫在处理之间和随着时间的推移而不同。治疗-
用肽聚糖抑制剂处理导致RB向IB发育的阻断,产生异常多倍体RB。
这些异常细胞在表达IB报告基因之前表达RB报告基因约10小时,但从未表达。
向EB记者施压或获得感染力。营养胁迫如色氨酸和铁饥饿也有报道
导致衣原体退出生殖发育周期并形成“异常”RB。我们的活细胞数据
表明这些细胞不表现出与用肽聚糖抑制剂处理的那些细胞相同的表型。
因此,目标1将确定与细胞增殖反应的异常RB的表型和基因表达谱。
容易产生传染性EB。IB到EB的发展是一个缓慢的过程,需要约10小时,直到最大EB
报告基因表达。因此,我们假设,IB可能会通过停止去-
直到营养素压力得到解决。然后,IB可以重新进入发育状态,
传染性后代因此,目标2将确定持续中IB向EB过渡的贡献。
tence.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SCOTT S GRIESHABER其他文献
SCOTT S GRIESHABER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SCOTT S GRIESHABER', 18)}}的其他基金
The role of aberrant gene expression in chlamydial persistence and reactivation
异常基因表达在衣原体持续存在和重新激活中的作用
- 批准号:
10289946 - 财政年份:2021
- 资助金额:
$ 18.18万 - 项目类别:
Genetic Regulation of Developmental Transitions in Chlamydia
衣原体发育转变的遗传调控
- 批准号:
10180885 - 财政年份:2018
- 资助金额:
$ 18.18万 - 项目类别:
Nucleoid structure and energy metabolism in chlamydial gene expression
衣原体基因表达中的核结构和能量代谢
- 批准号:
8771596 - 财政年份:2014
- 资助金额:
$ 18.18万 - 项目类别:
Nucleoid structure and energy metabolism in chlamydial gene expression
衣原体基因表达中的核结构和能量代谢
- 批准号:
8887302 - 财政年份:2014
- 资助金额:
$ 18.18万 - 项目类别:
The interaction of Chlamydia with the host cytoskeleton
衣原体与宿主细胞骨架的相互作用
- 批准号:
7880695 - 财政年份:2008
- 资助金额:
$ 18.18万 - 项目类别:
The interaction of Chlamydia with the host cytoskeleton
衣原体与宿主细胞骨架的相互作用
- 批准号:
7645691 - 财政年份:2008
- 资助金额:
$ 18.18万 - 项目类别:
The interaction of Chlamydia with the host cytoskeleton
衣原体与宿主细胞骨架的相互作用
- 批准号:
7532580 - 财政年份:2008
- 资助金额:
$ 18.18万 - 项目类别:
The interaction of Chlamydia with the host cytoskeleton
衣原体与宿主细胞骨架的相互作用
- 批准号:
8089260 - 财政年份:2008
- 资助金额:
$ 18.18万 - 项目类别:
The interaction of Chlamydia with the host cytoskeleton
衣原体与宿主细胞骨架的相互作用
- 批准号:
8289600 - 财政年份:2008
- 资助金额:
$ 18.18万 - 项目类别:
Characterization of Chlamydial Inclusion Migration
衣原体包涵体迁移的表征
- 批准号:
7142424 - 财政年份:2006
- 资助金额:
$ 18.18万 - 项目类别:
相似海外基金
SBIR Phase II: Development of a urine dipstick test that can guide immediate and appropriate antibiotic therapy for treatment of complicated urinary tract infections
SBIR II 期:开发尿液试纸测试,可以指导复杂尿路感染的立即和适当的抗生素治疗
- 批准号:
2213034 - 财政年份:2023
- 资助金额:
$ 18.18万 - 项目类别:
Cooperative Agreement
Personalized Antibiotic Therapy in the Emergency Department: PANTHER Trial
急诊科的个性化抗生素治疗:PANTHER 试验
- 批准号:
10645528 - 财政年份:2023
- 资助金额:
$ 18.18万 - 项目类别:
Strategies for improving the efficacy of combinatorial antibiotic therapy in chronic infections
提高慢性感染联合抗生素治疗疗效的策略
- 批准号:
10736285 - 财政年份:2023
- 资助金额:
$ 18.18万 - 项目类别:
A Novel Bone Targeted Antibiotic Therapy for the Treatment of Infected Fractures
一种治疗感染性骨折的新型骨靶向抗生素疗法
- 批准号:
10603486 - 财政年份:2023
- 资助金额:
$ 18.18万 - 项目类别:
Severe Cutaneous Adverse Reactions Following Outpatient Antibiotic Therapy: A Population-based Study
门诊抗生素治疗后的严重皮肤不良反应:一项基于人群的研究
- 批准号:
449379 - 财政年份:2020
- 资助金额:
$ 18.18万 - 项目类别:
Studentship Programs
Sex-Specific Differences in End-of-Life Burdensome Interventions and Antibiotic Therapy in Nursing Home Residents With Advanced Dementia
患有晚期痴呆症的疗养院居民的临终干预和抗生素治疗的性别差异
- 批准号:
422034 - 财政年份:2020
- 资助金额:
$ 18.18万 - 项目类别:
Optimizing outpatient parenteral antibiotic therapy to support hospital-in-the-home program across the unique environmental conditions of Australia
优化门诊肠外抗生素治疗,以支持澳大利亚独特环境条件下的家庭医院计划
- 批准号:
nhmrc : 1197866 - 财政年份:2020
- 资助金额:
$ 18.18万 - 项目类别:
Investigator Grants
Resistance evolution in the presence of combination antibiotic therapy
联合抗生素治疗下耐药性的演变
- 批准号:
2241853 - 财政年份:2019
- 资助金额:
$ 18.18万 - 项目类别:
Studentship
Host-pathogen interactions in antibiotic therapy for listeriosis
李斯特菌病抗生素治疗中宿主与病原体的相互作用
- 批准号:
18K07106 - 财政年份:2018
- 资助金额:
$ 18.18万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Multipurpose targeted nano-antibiotic therapy to fight tough infection in bones
多用途靶向纳米抗生素疗法可对抗骨骼中的严重感染
- 批准号:
9788269 - 财政年份:2018
- 资助金额:
$ 18.18万 - 项目类别: